Does melatonin do more than help you sleep?

Melatonin is a direct free radical scavenger that neutralizes hydroxyl radicals, hydrogen peroxide, singlet oxygen, and peroxynitrite¹. It also acts indirectly by stimulating antioxidant enzymes while suppressing pro-oxidant enzymes, and reportedly chelates transition metals involved in the Fenton/Haber-Weiss reactions¹. The title of the Reiter et al. review describes melatonin as an antioxidant that "under promises but over delivers".

Melatonin also upregulates endogenous antioxidant enzymes including glutathione peroxidase, superoxide dismutase, and catalase, while downregulating pro-oxidant enzymes like nitric oxide synthase². This dual action -- direct scavenging plus enzyme regulation -- makes it uniquely effective.

Immune modulation

Melatonin acts as an immunomodulator rather than a simple immune stimulant. It enhances the production of natural killer cells, T-helper cells, and immunoglobulins during immune challenge, while also having anti-inflammatory properties that help prevent excessive immune responses². This balance is why melatonin has been investigated in contexts ranging from infection response to autoimmune conditions. Carrillo-Vico et al. (2005) described melatonin as an "immune buffer" that amplifies immunity when needed and dampens it when overactivated².

Cancer research

Melatonin has shown anti-tumor activity in both in vitro and animal studies, particularly in hormone-dependent cancers. Menéndez-Menéndez and Martínez-Campa (2018) reviewed the evidence on hormone-dependent cancers, particularly breast cancer, noting that melatonin impairs tumor growth through multiple mechanisms: interfering with estrogen signaling, regulating the enzymes that make estradiol, modulating gene expression and epigenetic modifications, and acting as a promising adjuvant to chemotherapy or radiotherapy⁴. Night-shift workers, who have chronically suppressed melatonin due to light exposure at night, have consistently higher rates of breast and prostate cancer -- a relationship strong enough that the WHO classified night-shift work as a probable carcinogen (Group 2A).

Dosing: less is more

This is where most people go wrong. Over-the-counter melatonin supplements typically come in 3mg, 5mg, or 10mg doses, but research suggests that physiological doses of 0.3-0.5mg are often more effective for sleep than these supraphysiological amounts³. Lewy et al. found that low doses entrained circadian rhythms more effectively than high doses. Higher doses can cause morning grogginess, vivid dreams, and -- critically -- may desensitize melatonin receptors over time, potentially reducing your body's natural melatonin response.

Long-term supplementation at high doses may downregulate natural pineal production. If you do supplement, start with the lowest dose available (0.3-0.5mg), taken 30-60 minutes before your target bedtime.

Blue light destroys melatonin production

Your pineal gland produces melatonin in response to darkness. Blue light (460-480 nm wavelength) -- the dominant spectrum emitted by phones, tablets, and LED screens -- is the most potent suppressor of melatonin synthesis. Even moderate blue light exposure in the two hours before bed can delay melatonin onset by 90 minutes or more. This is covered in depth in the Sleep section on blue light and circadian rhythm.

Food sources of melatonin

Several foods contain meaningful amounts of melatonin:

• Tart cherries -- the richest known food source, particularly Montmorency cherries. Tart cherry juice concentrate has been shown in clinical trials to modestly improve sleep duration and quality.
• Pistachios -- contain exceptionally high levels of melatonin (about 660 ng/g), far more than most other nuts.
• Walnuts, almonds, and flaxseeds -- contain moderate amounts.
• Tomatoes, peppers, and mushrooms -- contain smaller but measurable quantities.

Getting melatonin from food delivers it in physiological doses alongside cofactors, which may be preferable to isolated supplements for general health maintenance.

Timing matters

Melatonin's effectiveness depends heavily on when you take it. For sleep, take it 30-60 minutes before your intended bedtime. Taking it too early can shift your circadian rhythm earlier than desired; taking it too late means it hasn't reached peak levels by the time you want to fall asleep. For circadian rhythm disorders (jet lag, shift work), the timing protocol is different and depends on the direction of the desired shift.

Reiter et al. (2016) reviewed the evidence that melatonin reduces oxidative stress under a remarkably large number of circumstances¹. It does so by a variety of means: direct detoxification of reactive oxygen and nitrogen species, and indirect effects that stimulate antioxidant enzymes while suppressing the activity of pro-oxidant enzymes. Melatonin also reportedly chelates transition metals involved in the Fenton/Haber-Weiss reactions, which reduces the formation of the highly toxic hydroxyl radical. Its high concentrations in mitochondria likely aid its capacity to resist oxidative stress and cellular apoptosis, and the review says there is credible evidence that it should be classified as a mitochondria-targeted antioxidant.

Immune buffering

Carrillo-Vico et al. (2005) reviewed melatonin's immunomodulatory role across multiple immune cell types². In immunosuppressed states, melatonin enhanced T-helper cell proliferation, increased IL-2 and IFN-gamma production, and stimulated natural killer cell activity. In inflammatory conditions, melatonin reduced pro-inflammatory cytokines (TNF-alpha, IL-6, IL-8) and inhibited NF-kB activation. The authors proposed that melatonin acts through specific membrane receptors (MT1 and MT2) on immune cells and through receptor-independent intracellular mechanisms, functioning as an immune system modulator that adjusts responses based on context rather than simply upregulating or downregulating immunity.

Low-dose superiority for circadian entrainment

Lewy et al. (2002) studied a blind individual with a free-running circadian period of 24.9 hours³. They administered melatonin at doses of 0.5mg, 5mg, and 20mg. The 0.5mg dose successfully entrained the circadian rhythm, while the higher doses did not -- they appeared to overwhelm melatonin receptors and produce a flattened dose-response curve. This finding supported the concept that melatonin's chronobiotic (clock-setting) effect operates through receptor-mediated pathways that saturate at low concentrations, meaning that higher doses can actually be less effective than physiological doses for circadian rhythm management.

Melatonin and hormone-dependent cancers

Menéndez-Menéndez and Martínez-Campa (2018) reviewed the research on melatonin's oncostatic effects in hormone-dependent cancers — breast, prostate and ovary⁴. Key findings included: melatonin interferes with estrogen signaling-mediated transcription, behaving as a selective estrogen receptor modulator (SERM); it regulates the production of estradiol through the enzymes involved in its synthesis, acting as a selective estrogen enzyme modulator (SEEM); and it is a promising adjuvant when included in chemotherapy or radiotherapy protocols for endocrine-responsive tumors. The review reports that data from several clinical trials and multiple in vivo and in vitro studies have documented that melatonin inhibits endocrine-dependent mammary tumors, and that similar results have been obtained in prostate and ovary cancer, with tumor metabolism, gene expression or epigenetic modifications modulated, cell growth impaired, and angiogenesis and metastasis inhibited.